five

SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals

收藏
NIAID Data Ecosystem2026-03-13 收录
下载链接:
http://datadryad.org/dataset/doi%253A10.5061%252Fdryad.dz08kps08
下载链接
链接失效反馈
官方服务:
资源简介:
The COVID-19 situation in Brazil is complex due to large differences in the shape and size of regional epidemics. Here we tested monthly blood donation samples for IgG antibodies from March 2020 to March 2021 in eight of Brazil’s most populous cities. The inferred attack rate of SARS-CoV-2 adjusted for seroreversion in December 2020, before the Gamma VOC was dominant, ranged from 19.3% (95% CrI 17.5% - 21.2%) in Curitiba to 75.0% (95% CrI 70.8% - 80.3%) in Manaus. Seroprevalence was consistently smaller in women and donors older than 55 years. The age-specific infection fatality rate (IFR) differed between cities and consistently increased with age. The infection hospitalisation rate (IHR) increased significantly during the Gamma-dominated second wave in Manaus, suggesting increased morbidity of the Gamma VOC compared to previous variants circulating in Manaus. The higher disease penetrance associated with the health system’s collapse increased the overall IFR by a minimum factor of 2.91 (95% CrI 2.43 – 3.53). These results highlight the utility of blood donor serosurveillance to track epidemic maturity and demonstrate demographic and spatial heterogeneity in SARS-CoV-2 spread. Methods We tested 97,950 blood donation samples for anti-SARS-CoV-2 IgG antibodies using the anti-N Abbott chemiluminescent microparticle immunoassay (CIMA). Tests were performed from March 2020 to March 2021 in eight Brazilian capitals: São Paulo, Manaus, Belo Horizonte, Curitiba, Fortaleza, Recife, Rio de Janeiro. We also tested blood samples from convalescent plasma donors to estimate the sensitivity of the assay. To estimate test specificity, we tested blood donation samples from São Paulo collected in February 2020, before the beginning of the SARS-CoV-2 epidemic in Brazil. In order to estimate the time-to-seroreversion distribution (used to correct for antibody waning), we also tested samples from repeat blood donors. Please see "Methods" section in the manuscript for more detailed information on this dataset.
创建时间:
2022-04-07
二维码
社区交流群
二维码
科研交流群
商业服务